David Bench - Net Worth and Insider Trading

David Bench Net Worth

The estimated net worth of David Bench is at least $10,544 dollars as of 2024-05-02. David Bench is the CFO of Enzo Biochem Inc and owns about 10,138 shares of Enzo Biochem Inc (ENZ) stock worth over $10,544. Details can be seen in David Bench's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Bench has not made any transactions after 2022-06-14 and currently still holds the listed stock(s).

Transaction Summary of David Bench

To

David Bench Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Bench owns 1 companies in total, including Enzo Biochem Inc (ENZ) .

Click here to see the complete history of David Bench’s form 4 insider trades.

Insider Ownership Summary of David Bench

Ticker Comapny Transaction Date Type of Owner
ENZ Enzo Biochem Inc 2022-06-14 CHIEF FINANCIAL OFFICER

David Bench Latest Holdings Summary

David Bench currently owns a total of 1 stock. David Bench owns 10,138 shares of Enzo Biochem Inc (ENZ) as of June 14, 2022, with a value of $10,544.

Latest Holdings of David Bench

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENZ Enzo Biochem Inc 2022-06-14 10,138 1.04 10,544

Holding Weightings of David Bench


David Bench Form 4 Trading Tracker

According to the SEC Form 4 filings, David Bench has made a total of 1 transactions in Enzo Biochem Inc (ENZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enzo Biochem Inc is the acquisition of 3,500 shares on June 14, 2022, which cost David Bench around $7,525.

Insider Trading History of David Bench

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Bench Trading Performance

GuruFocus tracks the stock performance after each of David Bench's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Bench is 4.76%. GuruFocus also compares David Bench's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Bench within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Bench's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Bench

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.81
Relative Return to S&P 500(%) 12.34

David Bench Ownership Network

Ownership Network List of David Bench

No Data

Ownership Network Relation of David Bench


David Bench Owned Company Details

What does Enzo Biochem Inc do?

Who are the key executives at Enzo Biochem Inc?

David Bench is the CHIEF FINANCIAL OFFICER of Enzo Biochem Inc. Other key executives at Enzo Biochem Inc include 10 percent owner James G. Wolf , Chief Executive Officer Hamid Erfanian , and Interim CFO Patricia Eckert .

Enzo Biochem Inc (ENZ) Insider Trades Summary

Over the past 18 months, David Bench made no insider transaction in Enzo Biochem Inc (ENZ). Other recent insider transactions involving Enzo Biochem Inc (ENZ) include a net purchase of 26,800 shares made by James G. Wolf , and a net purchase of 100,000 shares made by Hamid Erfanian .

In summary, during the past 3 months, insiders sold 0 shares of Enzo Biochem Inc (ENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzo Biochem Inc (ENZ) were sold and 126,800 shares were bought by its insiders, resulting in a net purchase of 126,800 shares.

Enzo Biochem Inc (ENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enzo Biochem Inc Insider Transactions

No Available Data

David Bench Mailing Address

Above is the net worth, insider trading, and ownership report for David Bench. You might contact David Bench via mailing address: Enzo Biochem, Inc., 527 Madison Avenue, New York Ny 10022.

Discussions on David Bench

No discussions yet.